Target intelligence / Profile preview

Corneal endothelial and epithelial ion transport machinery

Molecular classification
Ion channel, Transporter, Enzyme, Aquaporin
01

Overview

The corneal endothelial and epithelial ion transport machinery is a complex system of membrane proteins, including the Na+/K+-ATPase pump, carbonic anhydrases (CA-II and CA-IV), and various ion channels (e.g., CFTR, ENaC) and transporters (e.g., SLC4A4, SLC4A11). This machinery is responsible for maintaining the cornea in a state of relative dehydration, known as deturgescence, which is essential for optical transparency (1.1.2, 1.1.4). In the endothelium, the 'pump-leak' mechanism counteracts the natural swelling pressure of the corneal stroma by actively transporting ions into the aqueous humor, followed passively by water (1.2.2). Dysfunction of these transport processes, often due to genetic mutations or aging, leads to corneal edema and vision loss, as seen in Fuchs' endothelial corneal dystrophy (1.2.1). Pharmacological modulation of this machinery is used to treat glaucoma via carbonic anhydrase inhibition and is being explored for treating dry eye disease and corneal endothelial disorders (1.3.1, 1.3.2).

Other names
Corneal pump-leak mechanismCorneal hydration control systemCorneal endothelial pumpCorneal epithelial ion transport systemCorneal deturgescence machinery
02

Mechanism of action

The machinery maintains corneal transparency through the pump-leak mechanism, where active transport of ions (primarily Na+ and HCO3-) by the endothelium and epithelium creates an osmotic gradient that draws water out of the stroma. Drugs like carbonic anhydrase inhibitors reduce this transport to lower intraocular pressure, while experimental agents like CFTR activators or ENaC inhibitors modulate tear volume and composition for dry eye treatment.

03

Biological functions

Ion transportFluid homeostasisMaintenance of corneal transparencyCorneal deturgescenceNutrient transport
04

Disease associations

Corneal edemaFuchs' endothelial corneal dystrophyBullous keratopathyDry eye diseasePosterior polymorphous corneal dystrophy
05

Safety considerations

Corneal decompensationEndothelial cell toxicityOcular irritationBlurred visionSystemic metabolic acidosis
06

Interacting drugs

Dorzolamide

8 more in the full profile.

07

Biomarkers

Central corneal thickness (CCT)Endothelial cell density (ECD)Tear film osmolarityCorneal fluorescein staining

Beyond the preview

Go deeper on Corneal endothelial and epithelial ion transport machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal endothelial and epithelial ion transport machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call